chr12-112919404-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_016816.4(OAS1):​c.1054G>A​(p.Ala352Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.678 in 1,602,930 control chromosomes in the GnomAD database, including 374,330 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.75 ( 43990 hom., cov: 33)
Exomes 𝑓: 0.67 ( 330340 hom. )

Consequence

OAS1
NM_016816.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.117

Publications

55 publications found
Variant links:
Genes affected
OAS1 (HGNC:8086): (2'-5'-oligoadenylate synthetase 1) This interferon-induced gene encodes a protein that synthesizes 2',5'-oligoadenylates (2-5As). This protein plays a key role in innate cellular antiviral response, and has been implicated in other cellular processes like cell growth and apoptosis. Alternative splicing results in multiple transcript variants with different enzymatic activities. Polymorphisms in this gene have been associated with susceptibility to viral infection, including SARS-CoV-2, and diabetes mellitus, type 1. This gene is located in a cluster of related genes on chromosome 12. [provided by RefSeq, May 2022]
OAS1 Gene-Disease associations (from GenCC):
  • pulmonary alveolar proteinosis with hypogammaglobulinemia
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.1934328E-6).
BP6
Variant 12-112919404-G-A is Benign according to our data. Variant chr12-112919404-G-A is described in ClinVar as Benign. ClinVar VariationId is 1167216.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.922 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OAS1NM_016816.4 linkc.1054G>A p.Ala352Thr missense_variant Exon 6 of 6 ENST00000202917.10 NP_058132.2 P00973-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OAS1ENST00000202917.10 linkc.1054G>A p.Ala352Thr missense_variant Exon 6 of 6 1 NM_016816.4 ENSP00000202917.5 P00973-1

Frequencies

GnomAD3 genomes
AF:
0.750
AC:
114022
AN:
152074
Hom.:
43924
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.930
Gnomad AMI
AF:
0.684
Gnomad AMR
AF:
0.767
Gnomad ASJ
AF:
0.500
Gnomad EAS
AF:
0.774
Gnomad SAS
AF:
0.708
Gnomad FIN
AF:
0.728
Gnomad MID
AF:
0.589
Gnomad NFE
AF:
0.657
Gnomad OTH
AF:
0.705
GnomAD2 exomes
AF:
0.715
AC:
178817
AN:
250208
AF XY:
0.704
show subpopulations
Gnomad AFR exome
AF:
0.936
Gnomad AMR exome
AF:
0.827
Gnomad ASJ exome
AF:
0.507
Gnomad EAS exome
AF:
0.787
Gnomad FIN exome
AF:
0.738
Gnomad NFE exome
AF:
0.659
Gnomad OTH exome
AF:
0.671
GnomAD4 exome
AF:
0.670
AC:
971906
AN:
1450738
Hom.:
330340
Cov.:
44
AF XY:
0.669
AC XY:
483124
AN XY:
722192
show subpopulations
African (AFR)
AF:
0.941
AC:
31483
AN:
33452
American (AMR)
AF:
0.820
AC:
36643
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.512
AC:
13320
AN:
26014
East Asian (EAS)
AF:
0.796
AC:
31555
AN:
39624
South Asian (SAS)
AF:
0.693
AC:
59548
AN:
85954
European-Finnish (FIN)
AF:
0.730
AC:
38958
AN:
53380
Middle Eastern (MID)
AF:
0.581
AC:
3342
AN:
5752
European-Non Finnish (NFE)
AF:
0.651
AC:
717099
AN:
1101818
Other (OTH)
AF:
0.666
AC:
39958
AN:
60032
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.428
Heterozygous variant carriers
0
14324
28648
42971
57295
71619
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18758
37516
56274
75032
93790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.750
AC:
114152
AN:
152192
Hom.:
43990
Cov.:
33
AF XY:
0.752
AC XY:
55991
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.930
AC:
38630
AN:
41544
American (AMR)
AF:
0.767
AC:
11726
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.500
AC:
1737
AN:
3472
East Asian (EAS)
AF:
0.774
AC:
3996
AN:
5164
South Asian (SAS)
AF:
0.709
AC:
3419
AN:
4824
European-Finnish (FIN)
AF:
0.728
AC:
7703
AN:
10584
Middle Eastern (MID)
AF:
0.585
AC:
172
AN:
294
European-Non Finnish (NFE)
AF:
0.657
AC:
44654
AN:
68002
Other (OTH)
AF:
0.708
AC:
1493
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1376
2753
4129
5506
6882
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
840
1680
2520
3360
4200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.680
Hom.:
135179
Bravo
AF:
0.763
TwinsUK
AF:
0.644
AC:
2388
ALSPAC
AF:
0.660
AC:
2543
ESP6500AA
AF:
0.923
AC:
4067
ESP6500EA
AF:
0.646
AC:
5555
ExAC
AF:
0.716
AC:
86959
Asia WGS
AF:
0.767
AC:
2666
AN:
3478
EpiCase
AF:
0.638
EpiControl
AF:
0.644

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 94% of patients studied by a panel of primary immunodeficiencies. Number of patients: 89. Only high quality variants are reported. -

OAS1-related disorder Benign:1
May 17, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.83
T
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.21
DANN
Benign
0.89
DEOGEN2
Benign
0.023
T;T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.010
N
LIST_S2
Benign
0.44
T;.
MetaRNN
Benign
0.0000012
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N;.
PhyloP100
-0.12
PrimateAI
Benign
0.23
T
PROVEAN
Benign
-0.26
N;.
REVEL
Benign
0.018
Sift
Benign
0.51
T;.
Sift4G
Benign
0.24
T;.
Polyphen
0.0020
B;.
Vest4
0.034
ClinPred
0.0058
T
GERP RS
-1.4
Varity_R
0.055
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1131476; hg19: chr12-113357209; COSMIC: COSV52537702; COSMIC: COSV52537702; API